Dimitri Coucouvanis

Title: Innovations of Dimitri Coucouvanis

Introduction

Dimitri Coucouvanis is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of anti-angiogenic therapies, holding a total of 5 patents. His work focuses on developing compounds that can effectively treat diseases with a vascular component, such as cancer.

Latest Patents

One of his latest patents is titled "Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies." This invention discloses copper-binding compounds with improved properties and methods for their use in the prevention and treatment of angiogenic diseases. The advantages of this invention include enhanced stability of the compounds without a reduction in efficacy. Additionally, pharmaceutical compositions, therapeutic kits, and combination treatment methods are provided. Another significant patent involves methods and compositions for the treatment of angiogenic diseases, which include agents that can bind to copper and form a tripartite complex with proteins. These agents are utilized in the prevention and treatment of diseases with a vascular component, including solid tumors.

Career Highlights

Dimitri Coucouvanis has worked with prestigious institutions such as the University of Michigan and Attenuon, LLC. His research has led to advancements in therapeutic approaches for cancer treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Some of his notable coworkers include George J Brewer and Sofia D Merajver. Their collaborative efforts have contributed to the development of innovative therapies in the field of oncology.

Conclusion

Dimitri Coucouvanis is a distinguished inventor whose work in anti-angiogenic therapies has the potential to transform cancer treatment. His innovative patents and collaborations highlight his dedication to advancing medical science.